# PoreSpect

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/porespect

- Industry: Medical Devices & Equipment
- Headquarters: Guangzhou, China
- Website: www.porespect.com
- Latest round: Series A (Jan 11, 2026)
- Investors on record: 6

## About

Based in Guangzhou, China and founded in 2022, Guangzhou Insight Technology Co., Ltd., trading as PoreSpect, operates as a biotechnology company dedicated to providing solid-state nanopore detection equipment. It was jointly founded by PhDs from Stanford University and Imperial College of Technology. In July 2026, PoreSpect raised a pre-series A+ funding from Sunland Capital.

The company mainly develops biomacromolecule detection equipment, gene sequencers, and supporting reagent consumables based on solid-state nanopore single-molecule detection technology. The main product is solid-state nanopore detection equipment.

The company's revenue is generated by providing biomacromolecule detection equipment and gene sequencers.

The company will use the latest funding for the construction of solid-state nanopore chip testing and packaging production lines, R&D of testing products, and technological expansion in the advanced semiconductor field.

## Funding rounds

- Series A, Jan 11, 2026 — Leaguer Group, Lenovo Capital and Incubator Group, Value Capital
- Angel, Mar 22, 2024 — Tiantu Capital, IMO Ventures, Yael Capital

## Investors

- Tiantu Capital (https://capitalatlas.ai/funds/tiantu-capital) — Angel
- IMO Ventures (https://capitalatlas.ai/funds/imo-ventures) — Angel
- Yael Capital (https://capitalatlas.ai/funds/yael-capital) — Angel
- Leaguer Group (https://capitalatlas.ai/funds/leaguer-group) — Series A
- Lenovo Capital and Incubator Group (https://capitalatlas.ai/funds/lenovo-capital-and-incubator-group) — Series A
- Value Capital (https://capitalatlas.ai/funds/value-capital) — Series A